Re: Important Issue for Immunity Credentials

This is relevant to me.

We are working on an implementation of https://github.com/DP-3T/documents using
Zenroom.

An immunity credential example would help us.

Alex

El mar., 7 abr. 2020 a las 23:27, Adrian Gropper (<agropper@healthurl.com>)
escribió:

> HT to Juan C.
> https://unherd.com/2020/04/how-far-away-are-immunity-passports/
>
> I would ask: IWhat is the role of VC relative to local or decentralized
> governance to solving this issue?
>
> - Adrian
>
>
> On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick <
> info@verifiablecredentials.info> wrote:
>
>> Hi Moses
>>
>> over the last week or so we have developed a proof of concept COVID-19
>> Immunity Certificate application demonstrator built on our application
>> independent verifiable credential middleware. We would like to
>> participate in challenge (1) headed by Victoriano. I am currently in the
>> process of making a video of our demo
>>
>> Kind regards
>>
>> David
>>
>> On 08/04/2020 06:51, Moses Ma wrote:
>> > Hi Christopher et al,
>> >
>> > You're absolutely right. This is why we have recruited: Dr. Ab
>> > Osterhaus to join our team - he is one of the world's leading experts
>> > in coronaviruses, and his team was first to sequence the SARS virus,
>> > Dr. Tony Cox - a data scientist who specializes in epidemiology, and
>> > Triall.io - a clinical research organization that has run over 30
>> > Phase I-IV trials and is the developer of the first blockchain tool
>> > for clinical trials. All of our proposed pilots will adhere to
>> > clinical research methodologies that preserve patient privacy and
>> > insure validated data production.
>> >
>> > However, what we could use more of are privacy experts who can quickly
>> > produce innovative working solutions.
>> >
>> > Two challenges we've identified are: (1) the use of verifiable
>> > credentials to serve as digital certificates of immunity, and (2) the
>> > possibility of developing interoperable contact managers and globally
>> > unique IDs to enable international travel. A big thanks to Victoriano
>> > Giralt for stepping up to manage the first one, but I think we still
>> > need to find a MacGyvered approach to solving the second... in a way
>> > that has a low barrier to federation and adoption. To be brutally
>> > honest, we are triaging a solution, and we need to see reality clearly
>> > as to whether DIDs can add value short term.
>> >
>> > If you'd like to work on these sub-projects, please let me know.
>> > Again, this is an action-primary team that will need to deliver
>> > software on an super-agile basis.
>> >
>> > Anyway, I promised to share the recording of our first call so you
>> > know what we're up to, and you can find it here:
>> >
>> https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0
>> >
>> > Finally, I'll try to make time for CCG calls, but I'm getting
>> > exponentially busier these days.
>> >
>> >
>> > Stay healthy everyone!
>> >
>> > Moses
>> >
>> >
>> > PS, thisis a very interesting article about user acceptance of contact
>> > managers:https://045.medsci.ox.ac.uk/user-acceptance - respondents
>> > were most concerned about “government using the app as an excuse to
>> > increase surveillance after the epidemic”.
>> >
>> >
>> > <https://045.medsci.ox.ac.uk/user-acceptance>
>> >
>> > On 4/7/20 10:19 AM, Christopher Allen wrote:
>> >> As was discussed briefly in the call today, if we are going to talk
>> >> about #Covid19 technology solutions, we must partner with health &
>> >> epidemiological experts to do it right.
>> >>
>> >> For instance, it has been proposed that we support some kind of
>> >> digital immunity certificate. Even if we ignore its possible
>> >> human-rights & privacy risks, it can have still have risky public
>> >> health care choices:
>> >>
>> >> https://unherd.com/2020/04/how-far-away-are-immunity-passports/
>> >>
>> >> “If you issue immunity passports on this basis, /barely a third /of
>> >> the people you give them to will actually be immune. “There’s nothing
>> >> peculiar about this statistically,” Kevin McConway, an emeritus
>> >> professor of statistics at the Open University, told me. “It’s just
>> >> Bayes’ theorem <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The
>> >> likelihood of you having had Covid-19, if you’ve had a positive test,
>> >> depends not just on the accuracy of the test but on the prevalence in
>> >> the population you’re looking at.
>> >> …
>> >> In the end, that’s going to be a horribly cold-blooded calculation.
>> >> If you let people out when they’re 90% likely to be immune, that
>> >> means one person in 10 is going to be at risk of getting and
>> >> spreading the disease. Is that risk a price worth paying for reducing
>> >> the real costs (economic, social, physical, mental) of isolation? I
>> >> don’t know and I’m glad I don’t have to work it out. But someone has
>> >> to. And they’ll have to start by getting a reasonably effective test,
>> >> and testing hundreds of thousands of people, to see how many of us
>> >> have had it.”
>> >>
>> >> — Christopher Allen
>> >
>> >
>> > --
>> >
>> > *Moses Ma | Managing Partner*
>> >
>> > moses.ma@futurelabconsulting.com | moses@ngenven.com
>> >
>> > v+1.415.568.1068 | skype mosesma | /linktr.ee/moses.tao/
>> > <http://linktr.ee/moses.tao>
>> >
>> > FutureLab provides strategy, ideation and technology for breakthrough
>> > innovation and third generation blockchains.
>> >
>> > Learn more at /www.futurelabconsulting.com/
>> > <http://futurelabconsulting.com>. For calendar invites, please cc:
>> > mosesma@gmail.com
>> >
>> >
>> > Or whet your appetite by reading /Agile Innovation/
>> > <
>> http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A>
>>
>> > | /Quantum Design Sprint/
>> > <
>> https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864>
>>
>> > | my blog at /psychologytoday.com/
>> > <http://www.psychologytoday.com/blog/the-tao-innovation>.
>> >
>> > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE INTENDED
>> > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL IN ERROR,
>> > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR COPYING OF THIS
>> > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER IMMEDIATELY OF
>> > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE FROM YOUR
>> > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING; HARD COPY
>> > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING COMMITMENTS. FOR
>> > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM
>> >
>>
>>

-- 

Alex Puig

CTO

+34 678544357

alex@caelumlabs.com

Follow us! Twitter <https://twitter.com/caelumlabs> |

linkedin <https://www.linkedin.com/company/caelumlabs/> | Newsletter
<http://newsletter.caelumlabs.com/> | Gitlab <https://gitlab.com/caelumlabs>

IMPORTANT: The contents of this email and any attachments are confidential.
It is strictly forbidden to share any part of this message with any third
party, without a written consent of the sender. If you received this
message by mistake, please reply to this message and follow with its
deletion, so that we can ensure such a mistake does not occur in the future.